These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Clinical aspects and therapy of toxoplasmosis]. Mohr W Anglo Ger Med Rev; 1969 Oct; 5():125-39. PubMed ID: 5386882 [No Abstract] [Full Text] [Related]
6. [Congenital toxoplasmosis; observations on the recommendation of the Public Health Council]. van der Veen J Ned Tijdschr Geneeskd; 1984 Jan; 128(3):131-3. PubMed ID: 6700748 [No Abstract] [Full Text] [Related]
7. [The neurologic manifestations of toxoplasmosis]. Doutlik S; Kouba K Psychiatr Neurol Med Psychol (Leipz); 1974 Feb; 26(2):91-7. PubMed ID: 4842697 [No Abstract] [Full Text] [Related]
8. Research on congenital toxoplasmosis. Panaitescu D; Steriu D; Stefănoiu V; Pop M Roum Arch Microbiol Immunol; 1995; 54(4):313-24. PubMed ID: 8993124 [No Abstract] [Full Text] [Related]
9. The treatment of toxoplasmic posterior uveitis (chorioretinitis). Giles CL Am J Med Sci; 1966 Feb; 251(2):241-2. PubMed ID: 5295371 [No Abstract] [Full Text] [Related]
10. Simultaneous determination of pyrimethamine, sulfadiazine and N-acetyl-sulfadiazine in plasma for monitoring infants in treatment of congenital toxoplasmosis. Johannessen JK; Christiansen I; Schmidt DR; Petersen E; Hansen SH J Pharm Biomed Anal; 2005 Jan; 36(5):1093-8. PubMed ID: 15620537 [TBL] [Abstract][Full Text] [Related]
11. [Lymphadenitis caused by toxoplasmosis during gravidity -- an aetiological factor in congenital damage to the child (author's transl)]. Kouba K; Lasovská J; Moravcová E Zentralbl Gynakol; 1979; 101(14):918-20. PubMed ID: 532416 [TBL] [Abstract][Full Text] [Related]
12. [Chorioretinitis. What do we think about it in 1980?]. Goddé-Jolly D; Bonnin P Rev Prat; 1980 Feb; 30(7):303-9. PubMed ID: 7361039 [No Abstract] [Full Text] [Related]
13. The management of toxoplasmosis in pregnancy. Fuchs F; Kimball AC; Kean BH Clin Perinatol; 1974 Sep; 1(2):407-22. PubMed ID: 4549754 [No Abstract] [Full Text] [Related]
15. Delayed onset of severe neonatal toxoplasmosis. Al-Hamod D; Vauloup C; Goulet M; Zupan-Simunek V; Castel C; Boileau P J Perinatol; 2010 Mar; 30(3):231-2. PubMed ID: 20182429 [TBL] [Abstract][Full Text] [Related]
16. [Toxoplasmosis infections of the nervous system in children]. Tsuker MB; Bronshteĭn LE Zh Nevropatol Psikhiatr Im S S Korsakova; 1965; 65(7):975-80. PubMed ID: 5887500 [No Abstract] [Full Text] [Related]
17. [Apropos of a case of congenital toxoplasmosis]. Lacomme M; Lewin D; Amiel-Tison C; Cheynier JM Bull Fed Soc Gynecol Obstet Lang Fr; 1967; 19(3):208-13. PubMed ID: 5584037 [No Abstract] [Full Text] [Related]
18. [Current status of research on the prevention of congenital toxoplasmosis]. Iygiste AK; Zasukhin DN Sov Med; 1971; 34(12):22-7. PubMed ID: 5004616 [No Abstract] [Full Text] [Related]
19. [Treatment of congenital toxoplasmosis. Clinical and biological results (author's transl)]. Couvreur J; Nottin N; Desmonts G Ann Pediatr (Paris); 1980 Dec; 27(10):647-52. PubMed ID: 7212550 [No Abstract] [Full Text] [Related]
20. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination]. Couvreur J Presse Med; 1991 Jun; 20(24):1136. PubMed ID: 1830148 [No Abstract] [Full Text] [Related] [Next] [New Search]